NYSEAMERICAN:STXS Stereotaxis (STXS) Stock Price, News & Analysis $2.11 -0.08 (-3.65%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$2.11▼$2.2350-Day Range N/A52-Week Range$1.40▼$3.29Volume167,223 shsAverage Volume210,104 shsMarket Capitalization$178.63 millionP/E RatioN/ADividend YieldN/APrice Target$4.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort Interest Get Stereotaxis alerts: Email Address Stereotaxis MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside113.3% Upside$4.50 Price TargetShort InterestBearish4.65% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 2 Articles This WeekInsider TradingAcquiring Shares$29,927 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($0.24) to ($0.16) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.91 out of 5 stars 3.5 Analyst's Opinion Consensus RatingStereotaxis has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageStereotaxis has received no research coverage in the past 90 days.Read more about Stereotaxis' stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted4.65% of the float of Stereotaxis has been sold short.Short Interest Ratio / Days to CoverStereotaxis has a short interest ratio ("days to cover") of 9.4.Change versus previous monthShort interest in Stereotaxis has recently increased by 0.94%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldStereotaxis does not currently pay a dividend.Dividend GrowthStereotaxis does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for STXS. Previous Next 0.6 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 2 news articles for Stereotaxis this week, compared to 1 article on an average week.MarketBeat Follows5 people have added Stereotaxis to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Stereotaxis insiders have bought more of their company's stock than they have sold. Specifically, they have bought $29,927.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders18.52% of the stock of Stereotaxis is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions45.35% of the stock of Stereotaxis is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Stereotaxis' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Stereotaxis are expected to grow in the coming year, from ($0.24) to ($0.16) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Stereotaxis is -7.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Stereotaxis is -7.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioStereotaxis has a P/B Ratio of 16.23. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Deal MakerThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.Learn more about this much-needed advancement and investment opportunity here. About Stereotaxis Stock (NYSEAMERICAN:STXS)Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.Read More STXS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart STXS Stock News HeadlinesAugust 21, 2024 | insidertrades.comStereotaxis, Inc. (NYSEAMERICAN:STXS) Director Paul J. Isaac Purchases 8,095 SharesSeptember 3, 2024 | markets.businessinsider.comStereotaxis Robotic Technology to be Featured during Heart Rhythm Society’s HRX CongressSeptember 7, 2024 | Paradigm Press (Ad) Fmr CIA Advisor reveals PEACEMAKER superweaponKamala cannot get the “codes” to this superweapon. In Trump’s hands, it will restore America’s global dominance. It could also help Americans struggling under Bidenomics by potentially sending 5 military stocks SOARING. Historically, similar stocks have shot up 16,270% in just 18 months.September 3, 2024 | globenewswire.comStereotaxis Robotic Technology to be Featured during Heart Rhythm Society's HRX CongressAugust 25, 2024 | seekingalpha.comStereotaxis Receives CE Mark For GenesisX, Nears MAGiC ApprovalAugust 13, 2024 | finanznachrichten.deStereotaxis, Inc.: Stereotaxis Reports 2024 Second Quarter Financial ResultsAugust 13, 2024 | finanznachrichten.deStereotaxis, Inc.: Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisXAugust 13, 2024 | msn.comStereotaxis, Inc. (AMEX:STXS) Q2 2024 Earnings Call TranscriptSeptember 7, 2024 | Paradigm Press (Ad) Fmr CIA Advisor reveals PEACEMAKER superweaponKamala cannot get the “codes” to this superweapon. In Trump’s hands, it will restore America’s global dominance. It could also help Americans struggling under Bidenomics by potentially sending 5 military stocks SOARING. Historically, similar stocks have shot up 16,270% in just 18 months.August 13, 2024 | seekingalpha.comStereotaxis, Inc. (STXS) Q2 2024 Earnings Call TranscriptAugust 12, 2024 | marketwatch.comStereotaxis Gets Key EU Clearance to Market GenesisX Robotic SystemAugust 12, 2024 | finance.yahoo.comStereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisXAugust 12, 2024 | msn.comStereotaxis Q2 2024 Earnings PreviewAugust 12, 2024 | globenewswire.comStereotaxis Reports 2024 Second Quarter Financial ResultsAugust 12, 2024 | globenewswire.comStereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisXAugust 11, 2024 | markets.businessinsider.comHere's what to expect from Stereotaxis's earningsAugust 4, 2024 | uk.investing.comStereotaxis completes Access Point Technologies acquisitionJuly 22, 2024 | globenewswire.comStereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024See More Headlines Receive STXS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Stereotaxis and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/12/2024Today9/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorMedical Industry Electromedical equipment Sub-IndustryMedical Equipment Current SymbolNYSEAMERICAN:STXS CUSIPN/A CIKN/A Webwww.stereotaxis.com Phone(314) 678-6100Fax314-678-6159Employees130Year FoundedN/APrice Target and Rating Average Stock Price Target$4.50 High Stock Price Target$5.00 Low Stock Price Target$4.00 Potential Upside/Downside+113.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.27) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-20,710,000.00 Net Margins-87.38% Pretax Margin-87.38% Return on Equity-136.10% Return on Assets-51.26% Debt Debt-to-Equity RatioN/A Current Ratio2.29 Quick Ratio1.53 Sales & Book Value Annual Sales$26.77 million Price / Sales6.67 Cash FlowN/A Price / Cash FlowN/A Book Value$0.13 per share Price / Book16.23Miscellaneous Outstanding Shares84,660,000Free Float67,338,000Market Cap$178.63 million OptionableNot Optionable Beta1.57 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesDr. David Leo Fischel C.A.I.A. (Age 37)C.F.A., C.P.A., M.B.A., CEO & Chairman Comp: $62.2kMs. Kimberly R. Peery (Age 55)CFO & Secretary Comp: $251.76kMr. Keith GallowayVice President of OperationsMs. Laura Spencer GarthGeneral Counsel & SecretaryMr. Guy JudkowskiEquity Portfolio ManagerKey CompetitorsOrthoPediatricsNASDAQ:KIDSLiquidiaNASDAQ:LQDAParagon 28NYSE:FNASI-BONENASDAQ:SIBNIradimedNASDAQ:IRMDView All CompetitorsInsiders & InstitutionsPaul J IsaacBought 812 shares on 8/19/2024Total: $1,526.56 ($1.88/share)Paul J IsaacBought 8,095 shares on 8/15/2024Total: $15,380.50 ($1.90/share)Marshall Wace LLPSold 93,552 shares on 8/14/2024Ownership: 0.044%Marathon Trading Investment Management LLCSold 36,758 shares on 8/12/2024Ownership: 0.043%Renaissance Technologies LLCBought 154,400 shares on 8/9/2024Ownership: 0.591%View All Insider TransactionsView All Institutional Transactions STXS Stock Analysis - Frequently Asked Questions How have STXS shares performed this year? Stereotaxis' stock was trading at $2.87 at the beginning of 2024. Since then, STXS stock has decreased by 26.5% and is now trading at $2.11. View the best growth stocks for 2024 here. How were Stereotaxis' earnings last quarter? Stereotaxis, Inc. (NYSEAMERICAN:STXS) announced its quarterly earnings data on Monday, August, 12th. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of ($0.04) by $0.03. The company earned $4.50 million during the quarter, compared to the consensus estimate of $5.70 million. Stereotaxis had a negative net margin of 87.38% and a negative trailing twelve-month return on equity of 136.10%. Who are Stereotaxis' major shareholders? Stereotaxis' top institutional shareholders include Renaissance Technologies LLC (0.59%), Warberg Asset Management LLC (0.56%), Bank of New York Mellon Corp (0.23%) and Rhumbline Advisers (0.06%). View institutional ownership trends. How do I buy shares of Stereotaxis? Shares of STXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEAMERICAN:STXS) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stereotaxis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stereotaxis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
